Newsletter | September 12, 2024

09.12.24 -- A Year In, Sanofi's Journey With Plai AI Is Aiding Quality Decisions

NEW PODCAST EPISODE

Embracing Biotech Chaos With Memo's Erik van den Berg

Erik van den Berg is CEO and board member at Memo Therapeutics, and he's a student of biotech chaos. In fact, he's been embracing it with intention for the past 30 years. On the Business of Biotech, he walks us through the management of that chaos in specific detail. We cover it all, with van den Berg offering detailed insight into the guiding principles of navigating constant change in biotech.

FOCUS ON ANALYTICS & QUALITY

A Year In, Sanofi's Journey With Plai AI Is Aiding Quality Decisions

Sanofi has been a vocal advocate of AI/ML for years. Here's how it's using technology to facilitate the audit process and get to the bottom of deviations faster.

3D Biology: The Paradigm Shift In Next-Generation Drug Discovery

Learn how the transition to 3D biology is aiding scientists in their research and why the industry is embracing organoids for next-gen drug discovery.

The Transformative Power Of Digital Transformation

Discover the significance of digital transformation, its impact on various aspects of organizational operations, and the potential drawbacks of ineffective digital transformation.

In Silico Approaches Towards Automated Biomanufacturing

As part of MSAT, in silico approaches such as mechanistic modeling can be used to support and facilitate several activities in the production of biopharmaceuticals at all scales.

Must Know Analytical Techniques For Biopharma Developers

See how today’s leading instrumentation helps researchers get crucial information faster so they can speed up biopharmaceutical development and get to clinical trials faster with more reliable products.

ANALYTICS & QUALITY SOLUTIONS

Industrial Data Operations Software Solution For Life Sciences - HighByte

OsmoTECH XT Single-Sample Micro-Osmometer Demo - Advanced Instruments, Inc.

SPONSOR

The Cell & Gene Meeting on the Mesa is the sector's foremost annual conference bringing together senior executives in the industry. The program features expert-led panels, exclusive networking opportunities, and 100+ dedicated presentations by the leading companies in the sector. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-to-one meetings. Register today

FOCUS ON REGULATORY

How Can Biotechs Pivot After Failing Regulatory Approval?

Enrique Diloné has endured the highs and lows of the regulatory approval process and explains how his personal philosophy helps him pivot from disappointment to success.

Selecting The Right Single-Use Materials In Biopharmaceutical Manufacturing

Manufacturing operations are getting a boost thanks to single-use technologies, but how do biopharmaceutical manufacturers choose the right materials for constructing their single-use solutions?

Harmonizing Regulatory Guidelines For Assay Validation

Explore a detailed process for validating ligand-binding assays, particularly for Fcγ receptor binding analytes or other structural isoforms.

Connect With Bioprocess Online: